Difference in Physico-Pharmaceutical Properties between Crystalline and Noncrystalline 9,3"-Diacetylmidecamycin

スポンサーリンク

概要

• 論文の詳細を見る

• The noncrystalline solid form 9,3"-diacetylmidecamycin (MOM), a new macrolide antibiotic obtained by chemical modification of midecamycin, was prepared by spraydrying and the difference in physico-chemical properties between the crystalline and noncrystalline forms was investigated. In differential scanning calorimetry (DSC) measurements, the noncrystalline solid always showed two DSC peaks in the curves ; one exothermic and the other endothermic. These are attributable to crystallization and melting, respectively. The apparent solubility of the noncrystalline solid could be determined in 0.2% hydroxypropylmethylcellulose solution but not in water and was much greater than that of the crystalline solid. When the residue during solubility measurements in water was monitored periodically by X-ray diffractometry, the noncrystalline solid was found to convert gradually to the less soluble crystalline form ; that is, the former was metastable in aqueous suspension. The conversion rate was distinctly temperature-dependent and the higher the temperature, the faster the crystallization occurred. Also, it was confirmed that the solubility of both the crystalline and the noncrystalline solid increased as the temperature was decreased. From the slopes of the van't Hoff plots, the heat of solution was estimated to be -10.9 kcal/mol for the crystalline solid and -7.3 kcal/mol for the noncrystalline solid. In addition, the appearance and the surface area of the noncrystalline solid obtained by spray-drying were examined by electron microscopy and by BET gas adsorption analysis. The spray-drying procedure increased the specific surface area to about four times that of the original crystals. It is considered that the noncrystalline MOM should have a better bioavailability than the crystalline form in vivo.

• 公益社団法人日本薬学会の論文
• 1981-09-25

著者

• 津田 泰之

  北里大薬

• 津田 泰之

  School Of Pharmaceutical Sciences Kitasato University

• 関口 慶二

  School of Pharmaceutical Sciences, Kitasato University

• 佐藤 豊美

  Pharmaceutical Development Laboratories, Meiji Seika Kaisha, Ltd.

• 岡田 明

  Pharmaceutical Development Laboratories, Meiji Seika Kaisha, Ltd.

• 佐藤 豊美

  Pharmaceutical Development Laboratories Meiji Seika Kaisha Ltd.

• 関口 慶二

  School Of Pharmaceutical Sciences Kitasato University

• 岡田 明

  Pharmaceutical Development Laboratories Meiji Seika Kaisha Ltd.

関連論文

• 小腸アベイラビリティの予測法の検討
• Caco-2細胞における digoxin の膜透過性の検討
• セファロスポリン系抗生物質の経口吸収率の予測に関する検討
• Thermochemical Study of Theophyline and Its Hydrate
• Solvate Formation of Griseofulvin with Alkyl Halide and Alkyl Dihalides
• Spray Drying of Griseofulvin Solution Forming Its Solvate
• Hydrogen Fluoride Adduct Formation of Medicinal Compounds and Its Application to Particle Size Reduction(Pharmaceutical)
• Water Content and Dehydration Behavior of Crystalline Caffeine Hydrate
• Kinetic Study of the Dehydration of Sulfaguanidine under Isothermal Conditions
• Changes in Surface Appearance of Silver Chloride De-ammoniated after Complexation with Liquid, Gaseous and Aqueous Ammonia
• Thermal Analysis of Systems Showing Apparently Horizontal Solidus and Liquidus
• Formation of Ammonia Adducts of Several Steroids and Their Application to Particle Size Reduction
• Thermal Analysis of Griseofulvin-Chloroform System by High Pressure Differential Scanning Calorimetry
• Solvate Formation of Sulfathiazole with Acetone, 2-Butanone, 2-Pentanone and dioxane, and Its Application to Particle Size Reduction
• Thermal, Physicochemical, and Micromeritic Properties of Freeze-dried Chloramphenicol Palmitate
• 調剤における固体医薬品の湿式(仲介)粉砕
• サルファ剤とジメチルアミン間の分子付加物の形成とその微粉化への応用性
• バルビツール酸誘導体, その関連化合物とジメチルアミン間の分子付加物の形成ならびにその微粉化への応用
• バルビツール酸誘導体とジメチルアミン間の分子付加物の形成
• Size Reducibility of Sulfathiazole by Heat Transition and Subsequent Ball-milling
• Studies on Methods of Particle Size Reduction of Medicinal Compounds. VIII. Size Reduction by Freeze-Drying and the Influence of Pharmaceutical Adjuvants on the Micromeritic Properties of Freeze-Dried Powders
• Ammonia Adducts of Barbiturates and Their Application to Particle Size Reduction
• Ticarcillin異性体のヒトにおける体内動態
• Studies on the Method of Size Reduction of Medicinal Compounds. IV. Solvate Formation of Chloramphenicol and Its Application to Size Reduction
• Studies on the Method of Size Reduction of Medicinal Compounds. III. Size Reduction of Griseofulvin by Solvation and Desolvation Method using Chloroform. (3)
• Studies on the Method of Thermal Analysis of Organic Medicinals. VI. Simultaneous Measurement of the Differential Temperature and of the Dielectric Behavior
• ミニレジュー(平成11年度日本薬物動態学会年会シンポジウムより) : セファロスポリン系抗生物質のヒトにおける経口吸収率の予測
• TRM-147の吸収機構の解明
• Difference in Physico-Pharmaceutical Properties between Crystalline and Noncrystalline 9,3"-Diacetylmidecamycin
• スルホニル尿素誘導体とアンモニア間の分子付加物形成とその微粉化への応用
• Ammonia Adducts of Several Sulfonamides and Their Application to Particle Size Reduction
• Ammonia Adducts of Chloramphenicol and Chloramphenicol Palmitate and Their Application to Particle Size Reduction
• Ammonia Adducts of Chloramphenicol and Chloramphenicol Palmitate
• Dissolution Behavior of Solid Drugs. VI. Determination of Transition Temperatures of Various Physical Forms of Sulfanilamide by Initial Dissolution Rate Measurements
• Dissolution Behavior of Solid Drugs. V. Determination of the Transition Temperature and Heat of Transition between Barbital Polymorphs by Initial Dissolution Rate Measurements
• イオン交換による緩衝溶液の調製法とその教材的考察
• Dissolution Behavior of Solid Drugs. VII. Dissolution Rates of Sulfanilamide in Aqueous Carboxymethylcellulose Sodium Solutions with or without Sodium Chloride
• Studies on Methods of Particle Size Reduction of Medicinal Compounds. VI. Solvate Formation of Griseofulvin with Benzene and Dioxane
• 固形医薬品の溶解性状(第4報)溶解速度測定による粉末医薬品の有効表面積の測定
• Studies on the Method of Size Reduction of Medicinal Compounds. V. Size Reduction of Several Sulfonamides by Desorption of Ammonia from Their Ammonia Compounds
• Dissolution Behavior of Solid Drugs. III. Determination of the Transition Temperature between the Hydrate and Anhydrous Forms of Phenobarbital by Measuring Their Dissolution Rates
• Dissolution Behavior of Solid Drugs. II. Determination of the Transition Temperature of Sulfathiazole Polymorphs by Measuring the Initial Dissolution Rates
• Dissolution Behavior of Solid Drugs. I. Improvement and Simplification of Dissolution Rate Measurement, and Its Application to Solubility Determinations
• Studies on the Ethanol, n-Propanol and Isopropanol Solvates of Cortisone Acetate
• Determination of Particle Size and Its Distribution of Drug Powder by Dissolution Rate Measurements
• Studies on the Molecular Compound of Organic Medicinals.III. The Structure of the Molecular Compound of Sulfanilamide and Sulfathiazole
• 二波長測光法による牛血清アルブミン・アシッドバイオレット6B結合量の測定
• ふたたび薬局方の原点に戻って
• 牛血清アルブミンと結合したナフトール・イ***ーSの第二の結合形スペクトルの推定
• 相学的方法による医薬品の微粉化

もっと見る 閉じる

スポンサーリンク